NVR LCI (Tekturna HCT 150 mg-12.5 mg)
Generic Name: aliskiren/hydrochlorothiazide
Pill with imprint NVR LCI is White, Elliptical / Oval and has been identified as Tekturna HCT 150 mg-12.5 mg. It is supplied by Novartis Pharmaceuticals.
Tekturna HCT is used in the treatment of high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Tekturna HCT 150 mg-12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for NVR LCI
Tekturna HCT
- Generic Name:
- aliskiren/hydrochlorothiazide
- Imprint:
- NVR LCI
- Strength:
- 150 mg-12.5 mg
- Color:
- White
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Novartis Pharmaceuticals
- Inactive Ingredients:
- silicon dioxide
crospovidone
hypromelloses
ferric oxide red
lactose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
povidone
magnesium silicate
titanium dioxide
wheat starch
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
NDC Code | Labeler / Repackager |
---|---|
54868-6041 | Physicians Total Care Inc. (repackager) |
More about Tekturna HCT (aliskiren / hydrochlorothiazide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 4 Reviews – Add your own review/rating
- Drug class: miscellaneous antihypertensive combinations
Consumer resources
Professional resources
Other Formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.